Alzheimer's Treatment Centers of America (ATCA ) Only Treats Alzheimer's, Dementia, Cognitive Impairment and Memory Loss. ---- INVESTMENT OPPORTUNITY FOR ACCREDITED INVESTORS NOW AVAILABLE WITH SERIES A ROUND OF FINANCING. ---- ATCA is at the convergence of medicine and technology, harnessing the power of patented Artificial Intelligence (AI) protocol to help patients fight back against Alzheimer's disease and memory loss. It utilizes the immense analytical power of supercomputers to identify patterns, gives automated insights to physicians to improve decision making, streamlines diagnoses, and improves clinical outcomes. Each patient is unique. Consequently, ATCA has a data-intensive patient intake process. The amount of data that we gather on each patient is massive: - Labs- Cognitive assessment- DNA testing- Genetic food typing - Personal medical history- Family medical history - Social history- Exercise history- Prescriptions - Supplements- Treatments - Sleep issues -- literally thousands of data points.POSITIVE OBSERVATIONAL STUDY RESULTSIn the observational study of the AI protocol, 75% of the patients had no further decline in their mild cognitive impairment * TheStudy is peer reviewed and published in a scientific journal. (Study is available on website under Patient Resources)*Each patient is unique. No representation is being made that new patients would have similar results. Each patient responds to the protocol based on their current condition.SPEED OF ANALYSIS & HUMAN/AI INTERFACEThe AI creates a comprehensive 30-page report for practitioner in one day that could have taken the practitioner a year or more to prepareOur ATCA Practitioner is the Human/AI Interface and makes the final decisions for treatments. ESG OPPORTUNITY TO BENEFIT OTHERSAlzheimer's disease represents a huge unmet medical need for diagnosis and treatment.